2360 related articles for article (PubMed ID: 9863414)
1. [Functional evaluation in patients with kidney calculi].
Stojimirović B
Srp Arh Celok Lek; 1998; 126(9-10):394-8. PubMed ID: 9863414
[TBL] [Abstract][Full Text] [Related]
2. [Pathophysiology, diagnosis and conservative therapy in calcium kidney calculi].
Hess B
Ther Umsch; 2003 Feb; 60(2):79-87. PubMed ID: 12649986
[TBL] [Abstract][Full Text] [Related]
3. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.
Stoller ML; Chi T; Eisner BH; Shami G; Gentle DL
J Urol; 2009 Mar; 181(3):1140-4. PubMed ID: 19152919
[TBL] [Abstract][Full Text] [Related]
4. Metabolic abnormalities associated with calyceal diverticular stones.
Auge BK; Maloney ME; Mathias BJ; Pietrow PK; Preminger GM
BJU Int; 2006 May; 97(5):1053-6. PubMed ID: 16643491
[TBL] [Abstract][Full Text] [Related]
5. Body size and 24-hour urine composition.
Taylor EN; Curhan GC
Am J Kidney Dis; 2006 Dec; 48(6):905-15. PubMed ID: 17162145
[TBL] [Abstract][Full Text] [Related]
6. Reduction of renal stone risk by potassium-magnesium citrate during 5 weeks of bed rest.
Zerwekh JE; Odvina CV; Wuermser LA; Pak CY
J Urol; 2007 Jun; 177(6):2179-84. PubMed ID: 17509313
[TBL] [Abstract][Full Text] [Related]
7. Contributory metabolic factors in the development of nephrolithiasis in patients with medullary sponge kidney.
Yagisawa T; Kobayashi C; Hayashi T; Yoshida A; Toma H
Am J Kidney Dis; 2001 Jun; 37(6):1140-3. PubMed ID: 11382681
[TBL] [Abstract][Full Text] [Related]
8. Insulin resistance and low urinary citrate excretion in calcium stone formers.
Cupisti A; Meola M; D'Alessandro C; Bernabini G; Pasquali E; Carpi A; Barsotti G
Biomed Pharmacother; 2007 Jan; 61(1):86-90. PubMed ID: 17184967
[TBL] [Abstract][Full Text] [Related]
9. [Sodium excretion in children with lithogenic disorders].
Kovacević L; Kovacević S; Smoljanić Z; Peco-Antić A; Kostić N; Gajić M; Kovacević N; Jovanović O
Srp Arh Celok Lek; 1998; 126(9-10):321-6. PubMed ID: 9863402
[TBL] [Abstract][Full Text] [Related]
10. [Identification of lithogenic risk factors by a simplified first-line laboratory assessment in urinary calculi patients].
Glémain P; Prunet D
Prog Urol; 2006 Nov; 16(5):542-5. PubMed ID: 17175947
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of fasting hypercalciuria associated with increased citraturia in the ambulatory evaluation of nephrolithiasis.
Damasio B; Massarino F; Durand F; Banchero R; Bottino P; De Franchis V; Carmignani G; Cannella G
J Nephrol; 2005; 18(3):262-6. PubMed ID: 16013013
[TBL] [Abstract][Full Text] [Related]
12. Alkaline citrate in prevention of recurrent calcium oxalate stones.
Berg C
Scand J Urol Nephrol Suppl; 1990; 130():1-83. PubMed ID: 2291093
[TBL] [Abstract][Full Text] [Related]
13. Physiological and physiochemical correction and prevention of calcium stone formation by potassium citrate therapy.
Pak CY; Sakhaee K; Fuller CJ
Trans Assoc Am Physicians; 1983; 96():294-305. PubMed ID: 6679957
[TBL] [Abstract][Full Text] [Related]
14. Urinary risk factors for recurrent calcium stone formation in Thai stone formers.
Stitchantrakul W; Kochakarn W; Ruangraksa C; Domrongkitchaiporn S
J Med Assoc Thai; 2007 Apr; 90(4):688-98. PubMed ID: 17487123
[TBL] [Abstract][Full Text] [Related]
15. [Nephrolithiasis--rational etiological assessment].
Hess B; Ackermann D
Praxis (Bern 1994); 1997 Mar; 86(13):529-32. PubMed ID: 9157499
[TBL] [Abstract][Full Text] [Related]
16. The efficacy of dietary intervention on urinary risk factors for stone formation in recurrent calcium oxalate stone patients.
Siener R; Schade N; Nicolay C; von Unruh GE; Hesse A
J Urol; 2005 May; 173(5):1601-5. PubMed ID: 15821507
[TBL] [Abstract][Full Text] [Related]
17. Idiopathic recurrent calcium urolithiasis (IRCU): an acid meal challenge uncovers inappropriate pH of postprandial, fasting and daily urine: a cross-sectional study of male patients providing insight into post- and pre-load urinary stone substances, crystallization risk, presence of stones, renal transport and systemic metabolic factors.
Schwille PO; Wipplinger J
Eur J Med Res; 2008 Jul; 13(7):332-42. PubMed ID: 18700191
[TBL] [Abstract][Full Text] [Related]
18. Simplified protocol for biochemical evaluation of recurrent renal calcium stone disease.
Thode J; Finnerup B; Parvin C; Holmegaard SN; Skaarup P; Sørensen OH; Transbøl I
Miner Electrolyte Metab; 1988; 14(5):288-96. PubMed ID: 2845241
[TBL] [Abstract][Full Text] [Related]
19. Factors increasing the risk for stone formation in adult patients with cystic fibrosis.
Terribile M; Capuano M; Cangiano G; Carnovale V; Ferrara P; Petrarulo M; Marangella M
Nephrol Dial Transplant; 2006 Jul; 21(7):1870-5. PubMed ID: 16595587
[TBL] [Abstract][Full Text] [Related]
20. Prevention of recurrent nephrolithiasis.
Goldfarb DS; Coe FL
Am Fam Physician; 1999 Nov; 60(8):2269-76. PubMed ID: 10593318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
